Overview
The Efficacy of Intra-lesional Bleomycin Versus Intra-lesional Purified Protein Derivative in Treatment of Palmoplantar Warts
Status:
Unknown status
Unknown status
Trial end date:
2020-04-01
2020-04-01
Target enrollment:
Participant gender: